Polish supplement and pharmaceutical manufacturer with data modernization underway
Oleofarm manufactures dietary supplements, pharmaceutical raw materials, and cold-pressed oils across Poland with a 20-year operational history. The tech stack reveals a manufacturing-focused company (SAP, IFS, HPLC, GC-MS) paired with business intelligence tools (Tableau, Power BI) and now adopting Snowflake—indicating a shift toward centralized data infrastructure to support scaling. Hiring is accelerating across manufacturing and sales, with active projects centered on quality systems and integrated communications.
Oleofarm is a privately held pharmaceutical and supplement manufacturer based in Wrocław, Poland, employing 201–500 people. The company researches, produces, and sells dietary supplements, medical foods, pharmaceutical raw materials, and cold-pressed oils under its own brands. Operations span manufacturing, quality assurance, sales, and distribution across Poland. The current tech environment combines enterprise resource planning (SAP, IFS) with laboratory instrumentation (HPLC, GC-MS) for quality control, supplemented by analytics platforms (Tableau, Power BI) and e-commerce channels (Allegro integration).
Core systems: SAP and IFS for enterprise operations. Lab: HPLC and GC-MS for quality testing. Analytics: Tableau and Power BI. Infrastructure: GCP, PostgreSQL, Fortinet firewalls. Currently adopting Snowflake for data consolidation.
Active projects include Snowflake implementation, integrated quality management system development, 360° marketing campaigns, and packaging guidelines. Key challenges cited: innovation in product development and brand growth.
OLEOFARM's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.